Status:
UNKNOWN
Evaluation of Endorings-2-assisted Colonoscopy: a New Accessory for Improvement of Adenoma Detection Rate?
Lead Sponsor:
University Hospital Muenster
Conditions:
Colonic Adenoma
Colonic Polyp
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Screening colonoscopy for colorectal cancer is essential to diagnose and remove adenomas, precancerous stages of colorectal cancer. Unfortunately approximately 25 % of all adenomas are missed during t...
Eligibility Criteria
Inclusion
- Patients with an indication for a screening colonoscopy.
Exclusion
- Patients under 18 years, pregnancy
- Patients with prior colectomy or partial colectomy
- Patients with a history of colorectal cancer
- Patients with hereditary polyposis syndromes (FAP, HNPCC)
- Patients with a stricture of the colon
- Patients receiving anticoagulation prohibiting a colonoscopy
- inability to have a patient education
- bad conditions prohibiting a colonoscopy
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2022
Estimated Enrollment :
292 Patients enrolled
Trial Details
Trial ID
NCT03385434
Start Date
February 1 2018
End Date
February 1 2022
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unversity Clinic Muenster
Münster, North Rhine-Westphalia, Germany, 48149